HomeCompareSEPOF vs MRK

SEPOF vs MRK: Dividend Comparison 2026

SEPOF yields 362.12% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SEPOF wins by $5575.34M in total portfolio value
10 years
SEPOF
SEPOF
● Live price
362.12%
Share price
$0.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5575.40M
Annual income
$3,612,812,558.41
Full SEPOF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SEPOF vs MRK

📍 SEPOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSEPOFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SEPOF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SEPOF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SEPOF
Annual income on $10K today (after 15% tax)
$30,780.37/yr
After 10yr DRIP, annual income (after tax)
$3,070,890,674.65/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SEPOF beats the other by $3,070,882,346.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SEPOF + MRK for your $10,000?

SEPOF: 50%MRK: 50%
100% MRK50/50100% SEPOF
Portfolio after 10yr
$2787.73M
Annual income
$1,806,411,178.28/yr
Blended yield
64.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SEPOF
No analyst data
Altman Z
5.5
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SEPOF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSEPOFMRK
Forward yield362.12%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$5575.40M$56.8K
Annual income after 10y$3,612,812,558.41$9,798.13
Total dividends collected$5389.66M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SEPOF vs MRK ($10,000, DRIP)

YearSEPOF PortfolioSEPOF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$46,912$36,212.20$11,206$366.19+$35.7KSEPOF
2$208,962$158,765.82$12,650$502.35+$196.3KSEPOF
3$884,518$660,928.47$14,407$694.19+$870.1KSEPOF
4$3,561,063$2,614,629.36$16,585$967.82+$3.54MSEPOF
5$13,648,173$9,837,834.95$19,342$1,363.89+$13.63MSEPOF
6$49,841,490$35,237,944.87$22,913$1,947.19+$49.82MSEPOF
7$173,596,514$120,266,119.95$27,662$2,823.89+$173.57MSEPOF
8$577,228,205$391,479,935.47$34,159$4,173.35+$577.19MSEPOF
9$1,834,190,656$1,216,556,476.12$43,337$6,308.80+$1834.15MSEPOF
10$5,575,396,560$3,612,812,558.41$56,776$9,798.13+$5575.34MSEPOF

SEPOF vs MRK: Complete Analysis 2026

SEPOFStock

BluMetric Environmental Inc. provides solution-oriented consultation, design, products, and construction services to clients with environmental issues in Canada and internationally. The company offers professional services in the fields of environmental geosciences and engineering, industrial hygiene, occupational health and safety, renewable energy, water and waste water treatment, and environmental contracting and management. Its professional services include environmental permitting and compliance, environmental reporting, environmental site assessments, geomatics and data management, industrial hygiene, management systems, physical hydrogeology and clean water, property assessments and environmental due diligence, waste management, and waterpower and hydraulic structures, as well as occupational health, and safety and ergonomics. The company also provides SROD - shipboard reverse osmosis desalinator systems; and ROWPU- reverse osmosis water purification units that produce drinking water from nearly water source. The company serves commercial and industrial customers, military, mining, and governments. BluMetric Environmental Inc. is headquartered in Ottawa, Canada.

Full SEPOF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SEPOF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SEPOF vs SCHDSEPOF vs JEPISEPOF vs OSEPOF vs KOSEPOF vs MAINSEPOF vs JNJSEPOF vs ABBVSEPOF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.